Suppr超能文献

建立一种同时定量检测与呼吸健康相关的尿蛋白的多重质谱检测方法。

Development of a multiplex mass spectrometry method for simultaneous quantification of urinary proteins related to respiratory health.

机构信息

Transversal Activities in Applied Genomics, Sciensano, Brussels, Belgium.

Louvain Centre for Toxicology and Applied Pharmacology, University catholique de Louvain, Woluwe, Brussels, Belgium.

出版信息

Sci Rep. 2021 May 12;11(1):10107. doi: 10.1038/s41598-021-89068-9.

Abstract

Respiratory health of children is a health priority. Club cell protein (CC16) is an interesting biomarker of lung diseases and adverse effects towards the airway epithelium integrity. Osteopontin (OPN) and nuclear factor-kappa B (NF-κB) also play a role in respiratory health. The use of urine as biomarker source is useful in studies involving children but necessitates proper adjustment for physiological confounders influencing the urinary excretion, potentially characterized with beta-2-microglobulin (β2M), retinol binding protein 4 (RBP4) or myoglobin (MYO), as well as adjustment for possible renal dysfunction, characterized by human serum albumin (HSA). The simultaneous quantification of all these proteins in urine could facilitate children's health monitoring. A multiple reaction monitoring method (MRM) was developed and validated for the relative quantification of the seven mentioned urinary proteins. A total of nine proteotypic peptides were selected and used for the relative quantification of the seven proteins. The MRM method was completely validated for all proteins and partially for OPN. LOQ's ranged from 0.3 to 42.8 ng/ml, a good reproducibility and a good linearity were obtained across the analytical measurement range (r > 0.98). The method yielded varying correlations (r of 0.78, 0.71, 0.34 and 0.15 for CC16, β2M, RBP4 and HSA respectively) with available immunoassay data. It also allowed the identification and successful quantification of β2M and RBP4 as a protein candidate for adjustment of renal handling and dysfunction. All proteins were detected in the urine samples except for MYO and NF-κB. Our validated MRM-method is able to simultaneously quantify in urine biomarkers of airway epithelium integrity and biomarkers of variation in renal function and urinary dilution. This will allow to investigate further in future studies if urine can be used as a good surrogate source for biomarkers of airway epithelium integrity, and to understand the complex relationship between cause and effect in children's respiratory health monitoring.

摘要

儿童的呼吸健康是优先事项。克拉细胞蛋白 (CC16) 是肺部疾病和对气道上皮完整性的不良影响的一个有趣的生物标志物。骨桥蛋白 (OPN) 和核因子-κB (NF-κB) 在呼吸健康中也起着作用。使用尿液作为生物标志物来源在涉及儿童的研究中很有用,但需要对影响尿液排泄的生理混杂因素进行适当调整,这些混杂因素可能以β2-微球蛋白 (β2M)、视黄醇结合蛋白 4 (RBP4) 或肌红蛋白 (MYO) 为特征,还需要对可能的肾功能障碍进行调整,其特征是人血清白蛋白 (HSA)。同时定量测定尿液中的所有这些蛋白质可以促进儿童的健康监测。开发并验证了一种多重反应监测方法 (MRM),用于相对定量测定七种提到的尿液蛋白质。总共选择了 9 个特征肽,用于相对定量测定七种蛋白质。MRM 方法对所有蛋白质进行了完全验证,对 OPN 进行了部分验证。LOQ 的范围为 0.3 至 42.8ng/ml,获得了良好的重现性和良好的线性度在分析测量范围内(r>0.98)。该方法得到了不同的相关性(r 分别为 0.78、0.71、0.34 和 0.15,用于 CC16、β2M、RBP4 和 HSA)与现有的免疫测定数据。它还允许鉴定和成功定量β2M 和 RBP4,作为调整肾脏处理和功能障碍的蛋白质候选物。除了 MYO 和 NF-κB 外,所有蛋白质都在尿液样本中被检测到。我们验证的 MRM 方法能够同时定量测定尿液中气道上皮完整性的生物标志物和肾功能变化以及尿液稀释的生物标志物。这将使我们能够在未来的研究中进一步研究尿液是否可以作为气道上皮完整性生物标志物的良好替代来源,并了解儿童呼吸健康监测中因果关系的复杂关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd6c/8115669/80892514e267/41598_2021_89068_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验